The Latest Breaking News from Nasdaq

CNBC

Here's a recap of a few major headlines that hit the wire over the weekend.

Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share.

We are past the halfway mark of the June quarter reporting season, going by the number of S&P 500 companies that have reported their earnings.

Electric vehicle stocks had a mixed close in the week ending July 29, although market leader Tesla, Inc. (NASDAQ: TSLA) managed to build on its gains. Chinese EV stocks and some pure-play U.S. startups came under selling pressure despite a positive development on EV tax credits.

Benzinga has examined the prospects for many investors' favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro. 

The British scientist’s company employs artificial intelligence to drastically cut the time of drug development

The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis in patients 12 years of age or older. The company expects commercial launch of the product in Mid-August. Arcutis shares traded in a range of…

Thailand's digital economy has been scaling up over the past decade thanks to the power of various internet firms and one of the key players is Sea (Thailand), the local unit of the Nasdaq-listed firm Sea, which is behind e-commerce powerhouse Shopee.

Direxion Daily Select Large Caps & FANGs Bull 2X Shares (NYSE: FNGG) popped almost 5% after the market opened Friday, but a move higher was hampered by the general market, which may be in need of consolidation because the S&P 500 has soared 5% over the last three trading days.

The SPDR S&P 500 ETF Trust (NYSE: SPY) completed its best month since 2020 in July despite another aggressive Federal Reserve interest rate hike and ongoing inflation concerns.